Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectis Major Shareholding Notification 2020

Aug 4, 2020

1190_mrq_2020-08-04_b887af64-d84a-4616-a3c0-3f0cfdae4ee7.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SC 13D 1 a20-26532_1sc13d.htm SC 13D

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*SCHEDULE 13D*

*Under the Securities Exchange Act of 1934 (Amendment No.)**

*Cellectis S.A.*

(Name of Issuer)

*Ordinary Shares, nominal value €0.05 per share*

(Title of Class of Securities)

*15117K103 (American Depositary Shares, each representing one Ordinary Share)*

(CUSIP Number)

*Sophie Paquin*

*Bpifrance Participations S.A.*

*6-8, boulevard Haussmann*

*75009 Paris*

*France*

*+33 1 53 89 55 73*

*With copy to:*

*John C. Partigan*

*Nixon Peabody LLP*

*799 9th Street NW, Suite 500*

*Washington, DC 20001*

*(202) 585-8000*

((Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

*July 16, 2020*

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box x .

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

SEQ.=1,FOLIO='',FILE='C:\JMS\108224\20-26532-1\task9793679\26532-1-ba.htm',USER='108224',CD='Aug 4 20:45 2020'

CUSIP No. 15117K103 (American Depositary Shares, each representing one Ordinary Share) — 1 Name of Reporting Person Bpifrance Participations S.A.
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3 SEC Use Only
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
6 Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7 Sole Voting Power 0
8 Shared Voting Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
9 Sole Dispositive Power 0
10 Shared Dispositive Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
11 Aggregate Amount Beneficially Owned by Each Reporting Person 3,621,659 Ordinary Shares; 6,501,159 voting rights
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
13 Percent of Class Represented by Amount in Row (11) 8.5% of the Ordinary Shares
14 Type of Reporting Person (See Instructions) OO

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108224\20-26532-1\task9793679\26532-1-ba.htm',USER='108224',CD='Aug 4 20:45 2020'

CUSIP No. 15117K103 (American Depositary Shares, each representing one Ordinary Share) — 1 Name of Reporting Person Caisse des Dépôts
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3 SEC Use Only
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
6 Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7 Sole Voting Power 274,600
8 Shared Voting Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
9 Sole Dispositive Power 274,600
10 Shared Dispositive Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
11 Aggregate Amount Beneficially Owned by Each Reporting Person 3,896,259 Ordinary Shares; 6,775,759 voting rights
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
13 Percent of Class Represented by Amount in Row (11) 9.1% of the Ordinary Shares
14 Type of Reporting Person (See Instructions) OO

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108224\20-26532-1\task9793679\26532-1-ba.htm',USER='108224',CD='Aug 4 20:45 2020'

CUSIP No. 15117K103 (American Depositary Shares, each representing one Ordinary Share) — 1 Name of Reporting Person EPIC Bpifrance
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3 SEC Use Only
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
6 Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7 Sole Voting Power 0
8 Shared Voting Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
9 Sole Dispositive Power 0
10 Shared Dispositive Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
11 Aggregate Amount Beneficially Owned by Each Reporting Person 3,621,659 Ordinary Shares; 6,501,159 voting rights
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
13 Percent of Class Represented by Amount in Row (11) 8.5% of the Ordinary Shares
14 Type of Reporting Person (See Instructions) OO

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\108224\20-26532-1\task9793679\26532-1-ba.htm',USER='108224',CD='Aug 4 20:45 2020'

CUSIP No. 15117K103 (American Depositary Shares, each representing one Ordinary Share) — 1 Name of Reporting Person Bpifrance S.A.
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) o
(b) o
3 SEC Use Only
4 Source of Funds WC
5 Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o
6 Citizenship or Place of Organization France
Number of Shares Beneficially Owned by Each Reporting Person With 7 Sole Voting Power 0
8 Shared Voting Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
9 Sole Dispositive Power 0
10 Shared Dispositive Power 3,621,659 Ordinary Shares; 6,501,159 voting rights
11 Aggregate Amount Beneficially Owned by Each Reporting Person 3,621,659 Ordinary Shares; 6,501,159 voting rights
12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o
13 Percent of Class Represented by Amount in Row (11) 8.5% of the Ordinary Shares
14 Type of Reporting Person (See Instructions) OO

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\108224\20-26532-1\task9793679\26532-1-ba.htm',USER='108224',CD='Aug 4 20:45 2020'

*Item 1. Security and Issuer.*

This Schedule 13D (the “Schedule 13D”) relates to the American Depositary Shares, each representing one Ordinary Share, nominal value €0.05 per share (the “Ordinary Shares”) of Cellectis S.A. (the “Issuer”). The Issuer’s principal executive offices are located at 8, rue de la Croix Jarry, 75013 Paris, France.

Each of the Ordinary Shares entitles its holder to vote and be represented in the Issuer’s shareholders’ meetings in accordance with the provisions of French law and the Issuer’s By-laws. In general, each holder is entitled to one vote per Ordinary Share. However, the Issuer’s By-Laws provide that all shares held in registered form (actions nominatives) for more than two years will be granted double voting rights.

*Item 2. Identity and Background.*

This Schedule 13D is filed jointly by (i) Bpifrance Participations S.A., a société anonyme incorporated under the laws of the Republic of France (“Bpifrance Participations”), (ii) the Caisse des Dépôts, a French special public entity (établissement spécial) (“CDC”), (iii) EPIC Bpifrance, a French public institution of industrial and commercial nature (“EPIC”), and (iv) Bpifrance S.A. (“Bpifrance”), a société anonyme incorporated under the laws of the Republic of France. Bpifrance Participations, CDC, EPIC and Bpifrance are referred to herein collectively as the “Reporting Persons.” The principal address for CDC is 56, rue de Lille, 75007 Paris, France. The principal address for Bpifrance Participations, EPIC and Bpifrance is 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France.

Bpifrance Participations is a French public company specializing in the business of equity financing via direct investments or fund of funds. Bpifrance Participations is a wholly-owned subsidiary of Bpifrance, a French financial institution especially created for this purpose. CDC and EPIC each hold 50% of the share capital of Bpifrance and jointly control Bpifrance. CDC is principally engaged in the business of long-term investments. EPIC, a French public institution of industrial and commercial nature, is principally engaged in the holding of Bpifrance’s shares.

As of July 30, 2020, Bpifrance Participations held directly 3,621,659 Ordinary Shares and CDC may be deemed the beneficial owner of 3,896,259 Ordinary Shares, which includes 274,600 Ordinary Shares held directly. Neither Bpifrance nor EPIC held any Ordinary Shares directly. Bpifrance may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its sole ownership of Bpifrance Participations. EPIC may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its joint ownership and control of Bpifrance. CDC may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its joint ownership and control of Bpifrance.

Bpifrance Participations has held 2,879,500 Ordinary Shares for more than two years and thus has 5,759,000 voting rights from such shares.

Attached as Appendices A, B, C and D to Item 2 is information concerning the executive officers and directors of Bpifrance Participations, CDC, EPIC and Bpifrance, respectively, required to be disclosed in response to Item 2 and General Instruction C to Schedule 13D.

None of the Reporting Persons, nor, to the best of their knowledge, any of the persons referred to in Appendices A, B, C and D to Item 2 has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\105192\20-26532-1\task9793800\26532-1-bc.htm',USER='105192',CD='Aug 4 21:39 2020'

*Item 3. Source and Amount of Funds or Other Consideration.*

Bpifrance Participations and CDC each used their respective working capital to purchase the Ordinary Shares.

*Item 4. Purpose of Transaction.*

Through a series of open market purchases from June 22, 2020 through July 30, 2020, Bpifrance Participations has acquired 742,159 Ordinary Shares. In addition, through a series of open market purchases from June 3, 2020 through July 30, 2020, CDC has acquired 67,456 Ordinary Shares.

Ownership is stated as of July 30, 2020 and the ownership percentages are based on 42,275,882 Ordinary Shares outstanding as of December 31, 2019, as disclosed by the Issuer in its Form 20-F, filed as of March 5, 2020, for the fiscal year ended December 31, 2019.

All of the Ordinary Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Ordinary Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Ordinary Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein.

Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.

*Item 5. Interest in Securities of the Issuer.*

Please see Items 5, 6, 7, 8, 9 and 11 of each cover sheet for each filing entity.

As of July 30, 2020, Bpifrance Participations held directly 3,621,659 Ordinary Shares and CDC may be deemed the beneficial owner of 3,896,259 Ordinary Shares, which includes 274,600 Ordinary Shares held directly. Neither Bpifrance nor EPIC held any Ordinary Shares directly. Bpifrance may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its sole ownership of Bpifrance Participations. EPIC may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its joint ownership and control of Bpifrance. CDC may be deemed to be the beneficial owner of 3,621,659 Ordinary Shares, indirectly through its joint ownership and control of Bpifrance.

(a) See also the information contained on the cover pages of this Schedule 13D, which is incorporated herein by reference. The percentage of Ordinary Shares beneficially owned by each Reporting Person is based on 42,275,882 Ordinary Shares outstanding as of December 31, 2019, as disclosed by the Issuer in its Form 20-F for the fiscal year ended December 31, 2019.

(b) See the information contained on the cover pages of this Schedule 13D, which is incorporated herein by reference.

(c) There have been no reportable transactions with respect to the Ordinary Shares of the Issuer within the last 60 days by the Reporting Persons other than as described in this Schedule 13D.

(d) Not applicable.

(e) Not applicable.

7

SEQ.=1,FOLIO='7',FILE='C:\JMS\105192\20-26532-1\task9793800\26532-1-bc.htm',USER='105192',CD='Aug 4 21:39 2020'

*Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer*

Mr. Laurent Arthaud has served as a member of the Issuer’s board of directors since October 28, 2011. Mr. Arthaud has been the Managing Director of Life Sciences and Ecotechnologies for Bpifrance Investissement S.A.S. (formerly CDC Enterprises, a subsidiary of Caisse des Dépôts) since 2012.

*Item 7. Material to be Filed as Exhibits*

99.1 — Joint Filing Agreement dated as of August 4, 2020, by and among the Reporting Persons.

8

SEQ.=1,FOLIO='8',FILE='C:\JMS\105192\20-26532-1\task9793800\26532-1-bc.htm',USER='105192',CD='Aug 4 21:39 2020'

*SIGNATURE*

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: August 4, 2020
Bpifrance Participations S.A.
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs
Caisse des Dépôts
By: /s/ Eric Flamarion
Name: Eric Flamarion
Title: Head of Financial Investment Division
EPIC Bpifrance
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs
Bpifrance S.A.
By: /s/ Boubakar Dione
Name: Boubakar Dione
Title: Group Director of Legal Affairs

9

SEQ.=1,FOLIO='9',FILE='C:\JMS\105192\20-26532-1\task9793800\26532-1-bc.htm',USER='105192',CD='Aug 4 21:39 2020'

*APPENDIX A*

*Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of*

*BPIFRANCE PARTICIPATIONS S.A.*

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Participations S.A. are set forth below. The business address of each director and executive officer is Bpifrance Participations S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

*BOARD OF DIRECTORS*

Name Present Principal Occupation or Employment
NICOLAS DUFOURCQ Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance
VIRGINIE FERNANDES Director , Head of the Steering Department at Caisse des Dépôts
CATHERINE MAYENOBE Director , Secretary General of the Caisse des Dépôts Group
FREDERIC SAINT-GEOURS Director , President of the supervisory board of SNCF
FRENCH STATE, represented by CHARLES SARRAZIN Director , in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de l’Etat (French State Shareholding Agency)
CONSTANCE VALIGNY Director , Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury)
BARBARA LAVERNOS Director , Executive Vice-President Operations at L’Oreal
VICTOIRE AUBRY Director , Chief Financial Officer of Icade
SOPHIE STABILE Founder and CEO of Révérence
JULIEN TOGNOLA Chief , Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance

*EXECUTIVE OFFICERS*

Name Present Principal Occupation or Employment
NICOLAS DUFOURCQ Chief Executive Officer
JOSÉ GONZALO Executive Director
PIERRE BENEDETTI Chief Financial Officer

1

SEQ.=1,FOLIO='1',FILE='C:\JMS\105889\20-26532-1\task9793578\26532-1-be.htm',USER='105889',CD='Aug 4 19:56 2020'

*APPENDIX B*

*Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of*

*CAISSE DES DÉPÔTS*

The name, business address and present principal occupation or employment of each of the members of the Management Committee of Caisse des Dépôts are set forth below. The business address of each director and executive officer is Caisse des Dépôts, c/o 56, rue de Lille, 75007 Paris, France. Unless otherwise indicated, each such person is a citizen of France.

*MANAGEMENT COMMITTEE*

Name Present Principal Occupation or Employment
ERIC LOMBARD Chief Executive Officer of Caisse des Dépôts
OLIVIER SICHEL Deputy Chief Executive Officer of Caisse des Dépôts
NICOLAS DUFOURCQ Chief Executive Officer of Bpifrance
VIRGINIE CHAPRON-DU-JEU Director of Finance for the Caisse des Dépôts Group
PIERRE CHEVALIER Head of Legal and Tax Department
NATHALIE TUBIANA Risk Director of the Caisse des Dépôts Group
OLIVIER MAREUSE Chief Investment officer - Director of Savings Funds at Caisse des Dépôts
CATHERINE MAYENOBE Secretary General of Caisse des Dépôts Group
PAUL PENY Caisse des Dépôts Group Human Resources Director
SOPHIE QUATREHOMME Group Corporate Communications Director
MICHEL YAHIEL Pensions and Solidarity Director

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\105889\20-26532-1\task9793578\26532-1-be.htm',USER='105889',CD='Aug 4 19:56 2020'

*APPENDIX C*

*Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of*

*EPIC BPIFRANCE*

The name, business address and present principal occupation or employment of each of the directors and executive officers of EPIC Bpifrance are set forth below. The business address of each director and executive officer is EPIC Bpifrance, 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

*DIRECTORS*

Name Present Principal Occupation or Employment
CHRISTIAN BODIN Chairman, Chief Executive Officer of EPIC Bpifrance
PIERRE-LOUIS AUTIN Director , Head of department SITTAR at the Higher Education, Research and Innovation Ministry
YANN POUËZAT Director , Deputy Director at the Directorate of Financing, Industry and Market of the Ministry of Economy and Finance
ALBAN HAUTIER Director , Deputy Director at the General Directorate for Budget of the Ministry of Economy and Finance
SONIA BEURIER Director
MARIE ANNE LAVERGNE Director
NAOMI PERES Director

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\105889\20-26532-1\task9793578\26532-1-be.htm',USER='105889',CD='Aug 4 19:56 2020'

*APPENDIX D*

*Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of*

*BPIFRANCE S.A.*

The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance S.A. are set forth below. The business address of each director and executive officer is Bpifrance S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.

*DIRECTORS*

Name Present Principal Occupation or Employment
ERIC LOMBARD Chairman, Chief Executive Officer of the Caisse des Dépôts
NICOLAS DUFOURCQ Director, Chief Executive Officer of Bpifrance and Director, Chairman and Chief Executive Officer of Bpifrance Participations
GUILLAUME BOUDY Director , General Secretary for Public Investment
MARTIN VIAL Director , Chairman of the Agence des Participations de l’Etat (French State Shareholding Agency)
MARIE DELEAGE Director representing the employees of Bpifrance
PHILIPPE BAYEUX Director representing the employees of Bpifrance
VIRGINIE CHAPRON-DU JEU Director , Group Finance Director of the Caisse des Dépôts
CLAIRE DUMAS Director , Finance Director of Retail Banking France at Société Générale
CLAIRE CHEREMETINSKI Director , Head of Department of Bilateral and International Matters at the French Treasury (Ministry of Economy and Finance)
OLIVIER SICHEL Director, Deputy Chief Executive Officer of the Caisse des Dépôts
BERNARD DELPIT Director , Chief Financial Officer of Safran
ANNABEL ANDRE LAURENT Director
HAROLD HUWART Director
CAROLE ABBEY DUVAL Director
BARBARA LAVERNOS DUPUIS Director
DIANE SIMIU Director

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\105889\20-26532-1\task9793578\26532-1-be.htm',USER='105889',CD='Aug 4 19:56 2020'